cryptonews 1 week ago

Ripple News Brad Garlinghouse Slams $11B Gold Transfer as XRP Price Eyes $2

Garlinghouse slams slow gold settlement as XRP trades near $1.42. Full price analysis, key levels for $2, and an early-stage Bitco...

coindesk 1 week ago

Tether pushes into private credit with $400 million fund with Fasanara

The USDT issuer will help source lending opportunities and provide stablecoin payment infrastructure for Fasanara's private credit...

decrypt 1 week ago

Hunter Biden's LAPTOP Meme Coin Crashes 99% on Debut

LAPTOP hit a $190.81 peak within minutes of launching on Base, then shed roughly 99% as thin liquidity met a wave of selling.

coinpedia 1 week ago

Ripple News: SEC Filing Allegedly Names XRP Among Eligible Commodities For New E...

The post Ripple News: SEC Filing Allegedly Names XRP Among Eligible Commodities For New ETF Standards appeared first on Coinpedia...

coindesk 1 week ago

Bitcoin and Ethereum race quantum clock as U.S. backs $300 million hardware push

The threat is not here yet, but fault-tolerant machines and crypto’s migration plans are starting to converge on the same 2029 win...

blockonomi 1 week ago

Cathie Wood’s ARK Invest Exits AMD (AMD) and Palantir (PLTR), Pours $17M Into Ce...

ARK Invest sells AMD and Palantir shares worth $16M while buying $17M in Cerebras Systems, which posted 103% revenue growth. Detai...

coindesk 1 week ago

Consensys to split MetaMask into its own firm while staying silent on IPO

The existing company, Consensys Software Inc., will rebrand as MetaMask under Ethereum co-founder Joe Lubin as chairman and CEO.

cointelegraph 1 week ago

Tether, Fasanara launch $400M private credit fund targeting $3B

The evergreen fund will use USDT infrastructure to support asset-backed lending through fintech platforms in more than 60 countrie...

decrypt 1 week ago

Prediction Markets Abandon Cheap Oil as Brent Passes $100

Myriad's $120 side overtook $55 at the start of September, while Polymarket puts WTI reaching $100 this month at 59%.

blockonomi 1 week ago

Tyra Biosciences (TYRA) Shares Plunge 22% as Bladder Cancer Drug Trial Falls Sho...

Tyra Biosciences (TYRA) stock plunged 22% after its bladder cancer drug dabogratinib achieved a 64% response rate, missing the 70%...